• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AC Immune SA - Common Stock (NQ:ACIU)

    3.520 +0.160 (+4.76%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,086,739
    Open 3.310
    Bid (Size) 3.440 (200)
    Ask (Size) 3.510 (100)
    Prev. Close 3.360
    Today's Range 3.300 - 3.640
    52wk Range 1.430 - 4.000
    Shares Outstanding 99,197,829
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Unusual volume stocks in Friday's session ↗
    Unusual volume stocks are being observed in Friday's session. 
    Via Chartmill
    News headline image
    Why Is AC Immune Stock Up Over 23% Today? ↗
    ACIU shares surged over 23% after the company announced positive results from an interim Phase 2 study. 
    Via Stocktwits

    Performance

    YTD
    +4.8%
    +4.8%
    1 Month
    +26.6%
    +26.6%
    3 Month
    -0.6%
    -0.6%
    6 Month
    +76.9%
    +76.9%
    1 Year
    +18.1%
    +18.1%

    More News

    Read More
    News headline image
    AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune to Present at the Jefferies 2025 London Healthcare Conference
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune to Participate in Upcoming Investor Conferences
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    Eliminating Some Screened Stocks ↗
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    S&P 500 Moves Lower; US Crude Oil Inventories Increase ↗
    Via Benzinga
    Topics Stocks
    News headline image
    AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients ↗
    Via Benzinga
    News headline image
    Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday ↗
    Via Benzinga
    News headline image
    AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune to Present at the Jefferies 2024 London Healthcare Conference
    From AC Immune SA
    Via GlobeNewswire
    News headline image
    AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire

    Frequently Asked Questions

    Is AC Immune SA - Common Stock publicly traded?
    Yes, AC Immune SA - Common Stock is publicly traded.
    What exchange does AC Immune SA - Common Stock trade on?
    AC Immune SA - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for AC Immune SA - Common Stock?
    The ticker symbol for AC Immune SA - Common Stock is ACIU on the Nasdaq Stock Market
    What is the current price of AC Immune SA - Common Stock?
    The current price of AC Immune SA - Common Stock is 3.520
    When was AC Immune SA - Common Stock last traded?
    The last trade of AC Immune SA - Common Stock was at 01/05/26 04:00 PM ET
    What is the market capitalization of AC Immune SA - Common Stock?
    The market capitalization of AC Immune SA - Common Stock is 349.18M
    How many shares of AC Immune SA - Common Stock are outstanding?
    AC Immune SA - Common Stock has 349M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.